|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/506 | |
| A61P 31/12 | |||
| A61P 31/14 |
| (11) | Patento numeris | 1750713 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 05752861.4 |
| Europos patento paraiškos padavimo data | 2005-06-03 | |
| (97) | Europos patento paraiškos paskelbimo data | 2007-02-14 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2012-10-17 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/CA2005/000869 |
| Data | 2005-06-03 |
| (87) | Numeris | WO 2005/117885 |
| Data | 2005-12-15 |
| (30) | Numeris | Data | Šalis |
| 576573 P | 2004-06-04 | US |
| (72) |
RIVIERE, Phillippe, FR
RIVIERE, Marc, CA
READER, Stéphanie, CA
|
| (73) |
Bioniche Life Sciences Inc.,
231 Dundas St. East, Belleville, Ontario K8N 1E2,
CA
|
| (54) | USE OF IMATINIB TO TREAT LIVER DISORDERS AND VIRAL INFECTIONS |
| USE OF IMATINIB TO TREAT LIVER DISORDERS AND VIRAL INFECTIONS |